CN102613413B - 用于治疗仔猪白痢的饲料、中药、制备方法和应用 - Google Patents
用于治疗仔猪白痢的饲料、中药、制备方法和应用 Download PDFInfo
- Publication number
- CN102613413B CN102613413B CN2012101016633A CN201210101663A CN102613413B CN 102613413 B CN102613413 B CN 102613413B CN 2012101016633 A CN2012101016633 A CN 2012101016633A CN 201210101663 A CN201210101663 A CN 201210101663A CN 102613413 B CN102613413 B CN 102613413B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- chinese medicine
- feed
- weight
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 90
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000000654 additive Substances 0.000 claims abstract description 35
- 230000000996 additive effect Effects 0.000 claims abstract description 35
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 241000561734 Celosia cristata Species 0.000 claims abstract description 16
- 241000050051 Chelone glabra Species 0.000 claims abstract description 16
- 244000227573 Desmodium styracifolium Species 0.000 claims abstract description 16
- 244000268590 Euryale ferox Species 0.000 claims abstract description 16
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 16
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 16
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 16
- 241000096270 Swertia leducii Species 0.000 claims abstract description 16
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 16
- 210000001520 comb Anatomy 0.000 claims abstract description 16
- 239000001702 nutmeg Substances 0.000 claims abstract description 16
- 150000001413 amino acids Chemical class 0.000 claims abstract description 12
- 229930003231 vitamin Natural products 0.000 claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 239000011782 vitamin Substances 0.000 claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 12
- 244000270834 Myristica fragrans Species 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims description 29
- 235000019634 flavors Nutrition 0.000 claims description 26
- 235000013399 edible fruits Nutrition 0.000 claims description 18
- 235000003092 Artemisia dracunculus Nutrition 0.000 claims description 15
- 240000001851 Artemisia dracunculus Species 0.000 claims description 15
- 241001546929 Campsis grandiflora Species 0.000 claims description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 15
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 15
- 240000008669 Hedera helix Species 0.000 claims description 15
- 241000135026 Helminthostachys zeylanica Species 0.000 claims description 15
- 241001571466 Potentilla discolor Species 0.000 claims description 15
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 15
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 15
- 240000003152 Rhus chinensis Species 0.000 claims description 15
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000245665 Taraxacum Species 0.000 claims description 14
- 239000013589 supplement Substances 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 9
- 235000006708 antioxidants Nutrition 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 3
- -1 dihydropyridine ester Chemical class 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 229960003151 mercaptamine Drugs 0.000 claims description 3
- 230000010148 water-pollination Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 29
- 239000000203 mixture Substances 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000066764 Ailanthus triphysa Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241001649190 Campsis Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000000103 Potentilla erecta Species 0.000 abstract 1
- 235000016551 Potentilla erecta Nutrition 0.000 abstract 1
- 244000294611 Punica granatum Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000012530 fluid Substances 0.000 description 18
- 208000001848 dysentery Diseases 0.000 description 17
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 241000498779 Myristica Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 230000003115 biocidal effect Effects 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 210000000481 breast Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010023126 Jaundice Diseases 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 6
- 229960000740 enrofloxacin Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010059866 Drug resistance Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010046788 Uterine haemorrhage Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 235000011837 pasties Nutrition 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010028140 Mucous stools Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229960003405 ciprofloxacin Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 230000000369 enteropathogenic effect Effects 0.000 description 3
- 229960001625 furazolidone Drugs 0.000 description 3
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 3
- 229960000268 spectinomycin Drugs 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229960001139 cefazolin Drugs 0.000 description 2
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 2
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 2
- 229960004755 ceftriaxone Drugs 0.000 description 2
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 101100129922 Caenorhabditis elegans pig-1 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 208000004845 Cholecystolithiasis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101100520057 Drosophila melanogaster Pig1 gene Proteins 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014598 Encephalitis mumps Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004427 acute laryngopharyngitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960000479 ceftriaxone sodium Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- FDRNWTJTHBSPMW-GNXCPKRQSA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C([O-])=NN1C FDRNWTJTHBSPMW-GNXCPKRQSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
药物 | 恩诺沙星 | 环丙沙星 | 复达欣 | 利福平 | 先锋霉素 | V呋喃唑酮 | 氨苄青霉素 | 大观霉素 | 菌必治 | 氟哌酸 |
抑菌圈直径/mm | 17.6 | 16.5 | 14.3 | 9.0 | 15.5 | 9.4 | 13.5 | 13.0 | 17.0 | 12.5 |
组别 | 数量 | 治愈数 | 治愈率 | 有效数 | 有效率 | 总有效率 |
治疗组 | 150 | 117 | 78% | 33 | 22% | 100% |
对照组 | 100 | 42 | 42% | 31 | 31% | 73% |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101016633A CN102613413B (zh) | 2012-04-10 | 2012-04-10 | 用于治疗仔猪白痢的饲料、中药、制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101016633A CN102613413B (zh) | 2012-04-10 | 2012-04-10 | 用于治疗仔猪白痢的饲料、中药、制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102613413A CN102613413A (zh) | 2012-08-01 |
CN102613413B true CN102613413B (zh) | 2013-12-11 |
Family
ID=46553891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101016633A Expired - Fee Related CN102613413B (zh) | 2012-04-10 | 2012-04-10 | 用于治疗仔猪白痢的饲料、中药、制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102613413B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107232422A (zh) * | 2017-07-25 | 2017-10-10 | 安徽华米生物科技有限公司 | 一种用于防治仔猪白痢的饲料及其制备方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103478425B (zh) * | 2013-09-24 | 2015-07-29 | 杭州华缔集团有限公司 | 薇菜废弃物加工产品、其制备方法和应用 |
CN104082529B (zh) * | 2014-05-28 | 2016-05-11 | 张绪伟 | 用于防治仔猪黄白痢的饲料 |
CN104256096A (zh) * | 2014-10-08 | 2015-01-07 | 青岛农业大学 | 用于治疗仔猪痢疾的饲料添加剂及饲料 |
CN104799003A (zh) * | 2015-05-18 | 2015-07-29 | 山东新希望六和集团有限公司 | 一种10-30日龄仔猪的配合饲料及其制备方法 |
CN106039254A (zh) * | 2016-06-28 | 2016-10-26 | 宿松飞翔生态养殖有限公司 | 一种提高免疫力的家禽饲料添加剂 |
CN106334075A (zh) * | 2016-11-07 | 2017-01-18 | 四会市恒星智能科技有限公司 | 一种防治香猪肠道疾病的中兽药及其制备方法 |
CN108065078A (zh) * | 2017-12-22 | 2018-05-25 | 福建傲农生物科技集团股份有限公司 | 一种减少仔猪断奶应激综合征的环保型饲料添加剂及其制备方法与应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085084A (zh) * | 2007-06-26 | 2007-12-12 | 天津市畜牧兽医研究所 | 苦芩止痢口服液 |
CN101243828A (zh) * | 2008-03-21 | 2008-08-20 | 上海欣农饲料科技有限公司 | 一种水生植物饲料的制配方法 |
CN101411768A (zh) * | 2007-10-19 | 2009-04-22 | 天津生机集团有限公司 | 治疗仔猪黄白痢的纯中药组合物及其制备方法 |
CN101658579A (zh) * | 2009-08-06 | 2010-03-03 | 天津生机集团股份有限公司 | 治疗猪大肠杆菌病的中药组合物及其制备方法 |
CN101933556A (zh) * | 2009-07-02 | 2011-01-05 | 上海宏威兽药有限公司 | 一种畜禽用复合预混合饲料及其制备方法 |
-
2012
- 2012-04-10 CN CN2012101016633A patent/CN102613413B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085084A (zh) * | 2007-06-26 | 2007-12-12 | 天津市畜牧兽医研究所 | 苦芩止痢口服液 |
CN101411768A (zh) * | 2007-10-19 | 2009-04-22 | 天津生机集团有限公司 | 治疗仔猪黄白痢的纯中药组合物及其制备方法 |
CN101243828A (zh) * | 2008-03-21 | 2008-08-20 | 上海欣农饲料科技有限公司 | 一种水生植物饲料的制配方法 |
CN101933556A (zh) * | 2009-07-02 | 2011-01-05 | 上海宏威兽药有限公司 | 一种畜禽用复合预混合饲料及其制备方法 |
CN101658579A (zh) * | 2009-08-06 | 2010-03-03 | 天津生机集团股份有限公司 | 治疗猪大肠杆菌病的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
余华.中药在防治猪黄白痢病上的应用与机理研究.《中国畜牧兽医学会畜牧兽医生物技术学分会暨中国免疫学会兽医免疫分会第七次研讨会论文集》.2008,554-557. * |
马金秀.中药防治仔猪黄白痢的研究与应用.《现代农业科技》.2007,(第19期),179-180,182. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107232422A (zh) * | 2017-07-25 | 2017-10-10 | 安徽华米生物科技有限公司 | 一种用于防治仔猪白痢的饲料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102613413A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102613413B (zh) | 用于治疗仔猪白痢的饲料、中药、制备方法和应用 | |
CN102835609B (zh) | 具有防止仔猪腹泻作用的猪饲料和中药组合物 | |
CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
CN104012798B (zh) | 用于治疗母猪子宫内膜炎的饲料、中药组合物及制备方法 | |
CN102526525B (zh) | 一种用于治疗猪传染性胃肠炎的中药组合物 | |
CN103719609B (zh) | 一种哺乳期母猪饲料及其制备方法 | |
CN105233097A (zh) | 一种治疗仔猪腹泻的兽用中药组合物及其制备方法 | |
CN104256096A (zh) | 用于治疗仔猪痢疾的饲料添加剂及饲料 | |
CN103211096A (zh) | 一种抗球虫的中药饲料添加剂 | |
CN104068279A (zh) | 一种鳗鱼配合饲料及其制备方法 | |
CN104783003A (zh) | 用于小猪的中草药全价饲料及其制备方法 | |
CN102552769B (zh) | 一种治疗阴道炎的药物及其制备方法 | |
CN103585578A (zh) | 一种防治肉鸡大肠杆菌病的中药 | |
CN103815134A (zh) | 用于治疗猪致病性大肠杆菌病的饲料及中药组合物 | |
CN103239651B (zh) | 用于治疗奶牛隐性乳腺炎的中药 | |
CN102920957A (zh) | 一种预防猪沙门氏菌病的中草药添加剂及其猪饲料 | |
CN102743657B (zh) | 防治仔猪腹泻病的中药物组合物及其制备方法 | |
CN104543576B (zh) | 防治仔猪腹泻的复合植物提取物饲料添加剂及其制法应用 | |
CN105851592A (zh) | 一种具有缓释效果的母猪乳房炎饲料添加剂及制备方法 | |
CN103830616B (zh) | 治疗猪瘟的中药及其制备方法 | |
CN103141704A (zh) | 一种治疗猪肺疫的中药饲料 | |
CN103652490B (zh) | 用于治疗猪蓝耳病的猪饲料及其制备方法 | |
CN103202981A (zh) | 治疗动物外伤感染性疾病的药物 | |
CN103656315B (zh) | 用于治疗猪传染性胸膜肺炎的药物及其制备方法 | |
CN104547770A (zh) | 一种促进畜禽生长的发酵中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAIMEN FENGCHENG TOURIST ATTRACTIONS DEVELOPMENT C Free format text: FORMER OWNER: HU HAIBO Effective date: 20140110 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264006 YANTAI, SHANDONG PROVINCE TO: 226152 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140110 Address after: Yu Dong Wenfeng road 226152 Jiangsu Haimen city of Nantong Province Patentee after: Haimen Fengcheng tourist attractions development Co., Ltd. Address before: 264006 Yantai, Yantai economic and Technological Development Zone, Zhujianglu Road,,, Career Technical College Patentee before: Hu Haibo |
|
CB03 | Change of inventor or designer information |
Inventor after: Lin Huaibin Inventor before: Hu Haibo Inventor before: Cai Xiulei |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170401 Address after: 515833 Shantou City, Guangdong Province, the town of Chenghai District Hung Hung Hung village, three Patentee after: Chenghai City, Shantou District, Sichuan ecological farming cooperatives Address before: Yu Dong Wenfeng road 226152 Jiangsu Haimen city of Nantong Province Patentee before: Haimen Fengcheng tourist attractions development Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131211 Termination date: 20190410 |
|
CF01 | Termination of patent right due to non-payment of annual fee |